Taji Phillips is an Analyst on the Healthcare Services team at Deerfield and joined the Firm in 2024. Prior to Deerfield, Ms. Phillips was an Equity Research Senior Associate at Jefferies for more than two years. Before Jefferies, she was a Senior Consulting Analyst at Accenture. Ms. Phillips holds a B.S. in Biology, and an M.S. in Global Health from Duke University.

Trent Steelman is a Principal on the Healthcare Services team at Deerfield and joined the Firm in 2024. Prior to Deerfield, Mr. Steelman was an Associate at Silver Oak Services Partners. Before Silver Oak, he was an Investment Banking Senior Analyst at Ziegler and a Consulting Senior Analyst at Accenture. Mr. Steelman holds a B.A. in Mathematics & History from Northwestern University.

Anne Daub is a Partner on the Therapeutics team, and joined the Firm in 2024. Prior to Deerfield, Ms. Daub was a Vice President and Biotechnology Senior Analyst for T. Rowe Price for more than five years. Before this, she was a Senior Analyst at Soros Fund Management LLC and Citadel LLC. Prior to these roles, Ms. Daub was an Analyst at Visium Asset Management for eight years and also held positions at Bear Stearns & Co., Integrated Finance Ltd. and J.P. Morgan Securities Inc. She holds a graduate degree in Finance from H.E.C Graduate School of Management in Paris, France.  

Cody Parks is an Assistant Trader and joined the Firm in 2023. Prior to Deerfield, Mr. Parks was a Derivatives Trade Management Analyst at Credit Suisse for more than two years. He holds a B.S. in Finance and Risk Management from the University of Southern Maine. 

Moses Adubi is a Principal on the Healthcare Services team and joined the Firm in 2023. Prior to Deerfield, Mr. Adubi was a Healthcare Investor on the Venture Capital Investment Team at Optum Ventures for more than two years. Before Optum, he spent more than five years at Morgan Stanley, first as an Associate in the Private Wealth Management Global Rotational Program and then as an Analyst on the Global Technology Investment Banking Team. Mr. Adubi holds a B.A. in Government from Dartmouth College.

Michael Hurley, M.D., is a Principal on the Medical Technologies team and joined the Firm in 2022. Prior to Deerfield, Dr. Hurley was a Senior Associate at Blackstone Life Sciences where he focused on investments across medtech, biotech, and pharma. Before Blackstone, he served as an Assistant Clinical Professor at the University of California San Francisco (UCSF) and was a practicing physician at the San Francisco Veterans Affairs Medical Center. He completed his residency at UCSF and is board certified in Internal Medicine. Dr. Hurley holds a B.S. in Materials Science and Engineering from the Massachusetts Institute of Technology and an M.S. in Clinical Epidemiology and Biostatistics and an M.D. from Stanford University School of Medicine.

Michael Bergen is a Managing Director on the Medical Technologies team and joined the Firm in 2022. Prior to Deerfield, Mr. Bergen was a Senior Research Analyst for Millennium Partners for almost three years. He has also held roles at Point 72 for a combined seven years, most recently as Senior Research Analyst, and Apax Partners for over three years. Before these roles, Mr. Bergen held positions at Davidson Kempner Capital Management, J.W. Childs Associates and Citi. Mr. Bergen holds a B.A. in Engineering from Dartmouth College and an M.B.A. from the Wharton School of the University of Pennsylvania.

David Neustaedter, Ph.D., is a Venture Partner on the Medical Technologies team and joined the Firm in 2022. Prior to Deerfield, Dr. Neustaedter spent seven years as a Vice President, at Medtronic Ventures and, before Medtronic’s merger with Covidien, spent a further 7 years with Covidien including five years as a Vice President of Venture Capital. He has also held positions at Stryker Development, Leerink Swann/MEDACorp Strategy Consulting, Fletcher Spaght, and Braun Consulting. Dr. Neustaedter holds a B.Sc. in Cellular, Molecular, and Microbial Biology from University of Calgary, an M.B.A  from Yale University, and a Ph.D. in Molecular Biology from University of British Columbia.